drugset / Trial / NCT01068093

The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

NCT01068093

Phase 4 Unknown 120 enrolled Yokohama City University Medical Center
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effects of Ezetimibe on coronary plaque volume in patients with acute coronary syndrome.

Timeline

Start
2010-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg